Home » News » Boerse Express – ROUNDUP / New York Stock Closing: Earnings

Boerse Express – ROUNDUP / New York Stock Closing: Earnings

video-tag-article">

NEW YORK (dpa-AFX) – The recovery of the New York stock exchanges continued earlier this week. Investors expect consumer price data expected for Tuesday to indicate that inflationary momentum in the US will continue to slow. This would ease the pressure on the Fed as it tightens its monetary policy. The continued weakening of the US dollar was also indicative of a growing willingness to take risks on the part of investors.

Der Dow Jones Industrial closed on Monday with a 0.71% rise to 32,381.34 points after reaching a peak of 32,500 points, the highest level since the end of August. It was his fourth consecutive day of winning. The S&P 500 at the market level gained 1.06 percent to 4110.41 points. The high-tech Nasdaq 100
supported by significant price increases at the Apple industry heavyweight, up 1.20 percent to 12,739.72 points.

“The recent optimism among investors is likely due to hopes for a second month of slowing US inflation,” a market watcher said. If inflation data were behind this, a further positive trend in stock prices is conceivable this week. As early as August, the rise in US consumer prices had surprisingly slowed to 8.5 percent, while remaining at a very high level.

At the top of the Dow was Apple : With an increase of nearly 4%, the iPhone maker’s newspapers continued their recovery from the low since late July. After a good two weeks, they are back above the much-noted 200-day line, which is a popular long-term trend indicator among chart-oriented investors. The pre-order numbers for the new iPhone 14 have been listed as the course driver.

Otherwise, the Bristol Myers-Squibb pharmaceutical company has fallen below individual values up: after an initial price increase of over 8%, there was still a plus of 3.1% left. The shares benefited from FDA approval of the psoriasis drug Sotyktu. This was offset by a 4% price drop in Amgen
. So far the company has been strong with a drug in this niche, but now it faces more competition.

The industry also became Gilead Stocks
into a bigger winner, up 4.2%. The pharmaceutical company announced that it has reached a settlement in a patent lawsuit with several generic drug manufacturers. According to RBC analyst Brian Abrahams, this is a very positive development as the deal guarantees long-term revenue opportunities.

Stocks of Chevron oil companies Exxon Mobile
and ConocoPhillips it recorded gains of between 1.2 and 2.2 percent. This was aided by the increase in oil prices, which was supported by the drop in the dollar exchange rate.

The euro Monday briefly approached $ 1.02, the highest level in nearly four weeks. Eventually, it rebounded slightly to $ 1.0120. The European Central Bank (ECB) set the reference rate at 1.0155 (Friday: 1.0049) dollars. The dollar therefore cost € 0.9847.

US Treasuries temporarily gave up on gains on Monday. The 10-year Treasury futures contract recently fell 0.05% to 115.67 points. In return, the yield on these government bonds rose to 3.35%. / Tih / jha /

 ISIN  US2605661048  US6311011026  US78378X1072

AXC0246 2022-09-12 / 22: 34

Copyright dpa-AFX business news GmbH. All rights reserved. Redistribution, republication or permanent archiving without the express consent of dpa-AFX is not permitted.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.